Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Dr. Alan Miller on Benefits of Liquid Biopsy

April 29th 2015

Alan M. Miller, MD, PhD, Director of the Baylor Charles A. Sammons Cancer Center and Chief of Oncology for the Baylor Health Care System discusses the benefits of liquid biopsy.

The Precision Medicine Misconception

April 28th 2015

Amid the increasingly public discussion and often vigorous debate surrounding the general topic of precision cancer medicine, there appears to be a misconception of what the term is meant to imply.

Improving Treatment Requires Collaboration and Transparency

April 26th 2015

Application of Payment Reform Models in Oncology

April 26th 2015

Practical Application and Utility of EMRs

April 26th 2015

Coverage Decisions for Off-Label Treatments

April 26th 2015

Cost Containment's Impact on Oncology Practices

April 26th 2015

Assessing the Cost of Cancer Care

April 26th 2015

Bundled Payments in Community Oncology

April 26th 2015

Moving Away From Traditional Payment Models in Oncology

April 26th 2015

Addressing Cancer Health Disparities

April 26th 2015

Reining in the Cost of Cancer Care

April 26th 2015

Reimbursement for Oncology Treatment

April 26th 2015

Bundled Payment Models for Cancer-Related Costs

April 26th 2015

US Cancer-Related Healthcare Costs on the Rise

April 26th 2015

A Community in Unity

April 26th 2015

The Emperor of All Maladies documentary did a great job of capturing the innovative genius of mankind and the heroism of both oncologists and the patients who participated in their research.

BRCA Questions Resound

April 26th 2015

Given the higher risk of breast and ovarian cancer in BRCA mutation carriers, should broader screening for the abnormality be implemented?

Broad BRCA Screening is Becoming a Thorny Public Health Issue

April 23rd 2015

Population-based cancer screening using genetic sequencing technology is an idea worthy of careful consideration, but there are many challenges to implementing such a program.

Physician Quandary: Data Shortage, Surfeit Impinge on Precision Medicine

April 18th 2015

Like all new ideas or technologies, rapidly occurring changes present both opportunities and challenges for everyone involved, including government, patients, payers and physicians.

Oral Fluoropyrimidine TAS-102 in Refractory mCRC

April 16th 2015